Initial treatment patterns and survival in biliary tract cancer: A retrospective cohort study in Kyoto, Japan

This publication has 22 references indexed in Scilit:

• Perihilar cholangiocarcinoma resection: Is it beneficial for survival in elderly patients?
  Gastroenterología y Hepatología, 2023
• Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
  The Lancet, 2023
• Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
  Annals of Oncology, 2022
• Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
  NEJM Evidence, 2022
• The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: an exploratory analysis of JCOG1113
  Scientific Reports, 2022
• Biliary tract cancer
  The Lancet, 2021
• Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition
  Journal of Hepato-Biliary-Pancreatic Sciences, 2020
• Futibatinib, an investigational agent for the treatment of intrahepatic cholangiocarcinoma: evidence to date and future perspectives
  Expert Opinion on Investigational Drugs, 2020
• Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma
  Journal of Hepatology, 2019
• Recent trends in population-based cancer registries in Japan: the Act on Promotion of Cancer Registries and drastic changes in the historical registry
  International Journal of Clinical Oncology, 2014